History of falls in Parkinson disease is associated with reduced cholinergic activity - Wikidata - wikimedia - TriplyDB

History of falls in Parkinson disease is associated with reduced cholinergic activity

History of falls in Parkinson disease is associated with reduced cholinergic activity

http://www.wikidata.org/entity/Q37459699

about

Brainstem control of locomotion and muscle tone with special reference to the role of the mesopontine tegmentum and medullary reticulospinal systems Pedunculopontine Nucleus Stimulation: Where are We Now and What Needs to be Done to Move the Field Forward?Neuroimaging of mobility in aging: a targeted review Gait and cognition: a complementary approach to understanding brain function and the risk of falling Functional neuroimaging in Parkinson's disease Balance dysfunction in Parkinson's disease Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease Neuromechanical principles underlying movement modularity and their implications for rehabilitation Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration.Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease.Effect of low versus high frequency stimulation on freezing of gait and other axial symptoms in Parkinson patients with bilateral STN DBS: a mini-review.StartReact effects support different pathophysiological mechanisms underlying freezing of gait and postural instability in Parkinson's disease.The contribution of proprioceptive information to postural control in elderly and patients with Parkinson's disease with a history of falls.Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease Imaging: What can it tell us about parkinsonian gait?Neuroimaging as a window into gait disturbances and freezing of gait in patients with Parkinson's disease.Demographic study of parkinson's disease in Iran: Data on 1656 cases Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways.Neuroimaging in Parkinson disease: from research setting to clinical practice.Neuroimaging of Freezing of Gait.The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.Objective assessment of fall risk in Parkinson's disease using a body-fixed sensor worn for 3 days.White matter lesions in Parkinson disease.Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease.Cognitive contributions to gait and falls: evidence and implications Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.An update on brain imaging in parkinsonian dementia Rhinorrhea: a common nondopaminergic feature of Parkinson's disease.Predictors of cognitive impairment in an early stage Parkinson's disease cohort Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease.Effects of levodopa on regional cerebral metabolism and blood flow Clinical markers for identifying cholinergic deficits in Parkinson's disease Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?Glial response in the rat models of functionally distinct cholinergic neuronal denervations.Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline.

P2860

Q26779826-28CE4846-8D7C-4594-84C5-12D56DD75993 Q26852043-01C8DE3A-FA73-4B8B-A2D8-BA98563E3C2F Q26853463-551DDD2B-D208-45AB-8002-7605D26875CC Q26992286-570FFC5A-DB5D-47FE-84CD-AFAF743BA8AC Q27013767-7B38182B-DEF7-43B0-8ADF-B7D80A0579D2 Q28081188-2603ACE5-5334-4CB0-9764-95B38E326F3D Q28085513-25699E1F-0EB2-4F6E-AD3D-6A3F5C358B9D Q28088572-6E5ED293-DB9D-4B4D-811F-C528250E8AD4 Q30244035-A179DA39-09E2-4D7E-B250-B5E161A20FB6 Q30276531-0E278B6C-815C-4257-A14B-554DA4AF5F76 Q30356041-CE874CDC-2130-44F4-B61F-07B845ED6BBE Q30414951-DD861013-92E0-4DE6-B996-05A4174C621A Q30601341-513353D3-2423-4474-9656-946B68CD7DBA Q30665304-022708DE-5A97-43B6-94D7-E84A595EF1E2 Q30678856-A9288826-7CA2-4DB5-BE4A-C2B59CBA0CBE Q30679603-DC127B85-09E3-4B66-BBD6-EAA8D426F58E Q30697523-F9BD2446-A125-4C56-BC56-C8786BD8271D Q30746347-716F1E21-C29E-4B7E-84D0-9C3AB650EB6F Q30868628-6FD4324F-D78E-4E5C-BCCE-03B072CA2E1E Q30908233-73B361B9-8253-4150-8CC9-DBF19F8B608E Q31008210-CC360F5A-5357-4C52-9F7B-41173D1C61BE Q31145409-5523137A-E741-4113-ACBF-6F98AE6F66E8 Q33573126-F445FC47-057B-4836-8802-8FBA4713646C Q33827305-DB1A8A4D-F713-4724-A915-147136DA1E67 Q33917311-C70EA953-9C07-45EA-8C93-955A129E6CC9 Q33993839-03D564D1-35B1-48BC-924B-C3CC01D6B2E5 Q34135495-9EF6590F-898C-44DC-9469-9F867F5AE487 Q34170501-E28DA8E7-6DFD-49F9-962A-E4D88B859B17 Q34183061-70B092C9-7DE8-41EF-85B1-7E93E1B8DD4B Q34327937-656475B5-2F47-497D-B5BA-0981C3FFFF58 Q34440927-2D0A24C2-8F0C-41F4-8F97-0D392E9B9185 Q34531319-1BBF1A16-00C5-4B44-8815-66D67F01D70D Q34974523-20D0EAD2-28E0-42DB-8897-7E237C3D7820 Q35040119-91E40547-EBBC-435E-9681-7D576D543495 Q35054623-F3A31CBB-99DE-4D21-B5BE-A55B7641CE64 Q35070996-11B24C72-D9BF-471B-9C14-941E0D11A532 Q35163173-D28C463B-9FD3-49EF-84BB-A636757E25D9 Q35186701-4929B761-4846-4350-8F3A-C35842BFCAE9 Q35273342-0E2DCA42-A8DB-46A4-8817-B664268F8F95 Q35360176-D864EA56-7C7B-44E8-83EC-A383B67B57B1

P2860

History of falls in Parkinson disease is associated with reduced cholinergic activity

http://www.wikidata.org/entity/Q37459699

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

History of falls in Parkinson disease is associated with reduced cholinergic activity

@en

History of falls in Parkinson disease is associated with reduced cholinergic activity.

@nl

type

label

History of falls in Parkinson disease is associated with reduced cholinergic activity

@en

History of falls in Parkinson disease is associated with reduced cholinergic activity.

@nl

prefLabel

History of falls in Parkinson disease is associated with reduced cholinergic activity

@en

History of falls in Parkinson disease is associated with reduced cholinergic activity.

@nl

P1433

Q37459699-C4F5FB92-A495-41C3-86F9-384EC4A8F25E

P1476

Q37459699-6D9BDFE1-7F9D-44F1-AA95-A7EB98F35475

P2093

Q37459699-255AB73D-0A80-4792-9355-EF34F355ADE3

Q37459699-BECA1FF3-46C8-4902-9408-CC49930CCFF8

Q37459699-C10564D4-8E21-422F-9F83-A74B5163EADC

Q37459699-CBC8F266-1756-4301-8645-C7CF75AA6B74

Q37459699-CC292F21-3BA9-4B71-A890-C042AA9FEC21

Q37459699-EFCB93C0-FBB9-4D29-8B23-F7C70138DBBB

Q37459699-FECBE95D-EA72-409D-BA26-A69BEAC17477

P2860

Q37459699-096B0584-0B48-4A7C-812F-7BCBF036456A

Q37459699-09D7E7C1-1F7E-43DC-9E54-2C7CB16A399F

Q37459699-3000600F-4EEE-4D94-A34E-F53F3439B210

Q37459699-32C797BB-9944-456B-978D-236D461B0D9D

Q37459699-338B26BA-9AFE-401D-8B53-072E2A5DB99E

Q37459699-33ACC21B-428A-4245-8F07-91FC946ADBA2

Q37459699-3587F266-B845-4F02-962B-F13BFF6343F4

Q37459699-374F0D6F-ED9D-465F-A639-6E36B01180F5

Q37459699-3A4AB1DA-9419-4F2C-9A12-A57155A45B0B

Q37459699-41658AA2-7017-4DF2-BC79-8938CFCBF212

P304

Q37459699-AEC6E5DC-3315-4630-8902-2A1BFB8013A9

P31

Q37459699-BD9FFFD9-459A-46E0-8D50-F79C3FCEC4CF

P356

Q37459699-06A1260B-0433-444C-ADC5-406553EE1B7A

P407

Q37459699-DFA38632-E60A-495C-BC88-49622B40AB58

P433

Q37459699-6F393775-5B09-4233-B938-D30C9DD3D3C7

P478

Q37459699-ACE70C6A-9915-4817-BCC1-EF79C4638803

P577

Q37459699-E1594341-33A6-4314-BEFD-343F5D7EBB04

P698

Q37459699-9DE06E88-5BE9-45E3-9B0B-0285FD905A00

P921

Q37459699-08CD4CC4-08E5-415C-B8A1-AB6F2AF8708A

P932

Q37459699-38003D07-51B3-406D-8F86-EAB7D699AEBC

P356

WNL.0B013E3181C1DED6

P1433

P1476

History of falls in Parkinson disease is associated with reduced cholinergic activity

@en

P2093

K A Frey

http://www.w3.org/2001/XMLSchema#string

M A Kilbourn

http://www.w3.org/2001/XMLSchema#string

M L T M Müller

http://www.w3.org/2001/XMLSchema#string

N I Bohnen

http://www.w3.org/2001/XMLSchema#string

R A Koeppe

http://www.w3.org/2001/XMLSchema#string

R L Albin

http://www.w3.org/2001/XMLSchema#string

S A Studenski

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Parkinsonism: onset, progression and mortality

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Brain magnetic resonance imaging (MRI) in parkinsonian disorders.

The pedunculopontine nucleus: its role in the genesis of movement disorders.

The pedunculopontine nucleus and Parkinson's disease.

Changes in motor subtype and risk for incident dementia in Parkinson's disease.

Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Attention and the control of posture and gait: a review of an emerging area of research.

An update on falls.

P304

1670-1676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E3181C1DED6

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19917989

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2788804

http://www.w3.org/2001/XMLSchema#string